These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 26415994)

  • 1. Role of circulating-tumor DNA analysis in non-small cell lung cancer.
    Jiang T; Ren S; Zhou C
    Lung Cancer; 2015 Nov; 90(2):128-34. PubMed ID: 26415994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples.
    Ishii H; Azuma K; Sakai K; Kawahara A; Yamada K; Tokito T; Okamoto I; Nishio K; Hoshino T
    Oncotarget; 2015 Oct; 6(31):30850-8. PubMed ID: 26334838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
    Villaflor V; Won B; Nagy R; Banks K; Lanman RB; Talasaz A; Salgia R
    Oncotarget; 2016 Oct; 7(41):66880-66891. PubMed ID: 27602770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of serum DNA and pyrosequencing for the detection of EGFR mutations in non-small cell lung cancer.
    Akca H; Demiray A; Yaren A; Bir F; Koseler A; Iwakawa R; Bagci G; Yokota J
    Cancer Genet; 2013 Mar; 206(3):73-80. PubMed ID: 23491080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer.
    Wan R; Wang Z; Lee JJ; Wang S; Li Q; Tang F; Wang J; Sun Y; Bai H; Wang D; Zhao J; Duan J; Zhuo M; An T; Wu M; Chen Z; Yang Z; Wang J
    J Thorac Oncol; 2017 Sep; 12(9):1376-1387. PubMed ID: 28552765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of cell-free circulating tumor DNA testing for lung cancer.
    Santarpia M; Karachaliou N; González-Cao M; Altavilla G; Giovannetti E; Rosell R
    Biomark Med; 2016; 10(4):417-30. PubMed ID: 26974841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid clearance of circulating tumor DNA during treatment with AZD9291 of a lung cancer patient presenting the resistance EGFR T790M mutation.
    Vallée A; Audigier-Valette C; Herbreteau G; Merrien J; Tessonnier L; Théoleyre S; Denis MG
    Lung Cancer; 2016 Jan; 91():73-4. PubMed ID: 26612314
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical significance of circulating tumor cells and free DNA in non-small cell lung cancer.
    Isobe K; Hata Y; Kobayashi K; Hirota N; Sato K; Sano G; Sugino K; Sakamoto S; Takai Y; Shibuya K; Takagi K; Homma S
    Anticancer Res; 2012 Aug; 32(8):3339-44. PubMed ID: 22843912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR mutations in lung cancer: from tissue testing to liquid biopsy.
    Fenizia F; De Luca A; Pasquale R; Sacco A; Forgione L; Lambiase M; Iannaccone A; Chicchinelli N; Franco R; Rossi A; Morabito A; Rocco G; Piccirillo MC; Normanno N
    Future Oncol; 2015; 11(11):1611-23. PubMed ID: 26043215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer.
    Huang WL; Wei F; Wong DT; Lin CC; Su WC
    Biomed Res Int; 2015; 2015():340732. PubMed ID: 26448936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR array: uses in the detection of plasma EGFR mutations in non-small cell lung cancer patients.
    Yam I; Lam DC; Chan K; Chung-Man Ho J; Ip M; Lam WK; Chan TK; Chan V
    J Thorac Oncol; 2012 Jul; 7(7):1131-40. PubMed ID: 22610259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells and DNA for real-time EGFR detection and monitoring of non-small-cell lung cancer.
    He J; Tan W; Ma J
    Future Oncol; 2017 Apr; 13(9):787-797. PubMed ID: 28073294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What future for circulating tumor DNA? Current data and prospects in colorectal, non-small cell lung and pancreatic cancers].
    Pietrasz D; Pécuchet N; Fabre E; Blons H; Chevalier L; Taly V; Laurent-Puig P; Bachet JB
    Bull Cancer; 2016 Jan; 103(1):55-65. PubMed ID: 26790710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of liquid biopsies.
    Buder A; Tomuta C; Filipits M
    Curr Opin Oncol; 2016 Mar; 28(2):130-4. PubMed ID: 26730486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study.
    Pécuchet N; Zonta E; Didelot A; Combe P; Thibault C; Gibault L; Lours C; Rozenholc Y; Taly V; Laurent-Puig P; Blons H; Fabre E
    PLoS Med; 2016 Dec; 13(12):e1002199. PubMed ID: 28027313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer.
    Nie K; Jia Y; Zhang X
    Tumour Biol; 2015 Jan; 36(1):7-19. PubMed ID: 25352029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer.
    Kimura H; Kasahara K; Kawaishi M; Kunitoh H; Tamura T; Holloway B; Nishio K
    Clin Cancer Res; 2006 Jul; 12(13):3915-21. PubMed ID: 16818687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer.
    Yao Y; Liu J; Li L; Yuan Y; Nan K; Wu X; Zhang Z; Wu Y; Li X; Zhu J; Meng X; Wei L; Chen J; Jiang Z
    Oncotarget; 2017 Jan; 8(2):2130-2140. PubMed ID: 27791985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-educated platelet as liquid biopsy in lung cancer patients.
    Liu L; Lin F; Ma X; Chen Z; Yu J
    Crit Rev Oncol Hematol; 2020 Feb; 146():102863. PubMed ID: 31935617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.